SCHEMBL14040372

SCHEMBL14040372

COc1ccc2nc(-c3ccccc3)cc(C(N)O)c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
MEN1 O00255 1/20 0.63
KMT2A Q03164 1/20 0.63
PLA2G2A P14555 2/20 0.58
ALDH1A1 P00352 3/20 0.54
ACACA Q13085 1/20 0.52
CALCRL Q16602 2/20 0.52
AURKA O14965 1/20 0.50
AURKB Q96GD4 1/20 0.50
TACR3 P29371 4/20 0.49
HPGD P15428 3/20 0.49
LMNA P02545 2/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
CYP2D6 P10635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6534504 0.87 KDM4E (0.56) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A
SCHEMBL10199562 0.85 KDM4E (0.68) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A
SCHEMBL6498067 0.79 KDM4E (0.71) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A
SCHEMBL10610678 0.79 KDM4E (0.71) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A
SCHEMBL30064616 0.79 KDM4E (0.75) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A
SCHEMBL28350370 0.79 KDM4E (0.75) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A
SCHEMBL13757621 0.77 SMN1; SMN2 (1.00) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A
SCHEMBL10263305 0.77 KDM4E (0.73) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A
SCHEMBL14040263 0.76 PLA2G2A (0.77) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A
SCHEMBL12285330 0.76 KDM4E (0.71) KDM4ESMN1; SMN2MEN1KMT2APLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008116671-A1 2,3,4,9-TETRAHYDRO-1H-CARBAZOLES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-10-02 WO disclosed
EP-1975159-A1 2,3,4,9-Tetrahydro-1H-carbazoles Bayer Schering Pharma Aktiengesellschaft (DE) 2008-10-01 EP disclosed